The emergence of a new epidemic in humans often requires shifts in pathogen biology and/or changes in the human population structure. The methodology developed here can signal these events as anomalies in the expected number of new cases. Assuming no change of epidemiological conditions, knowledge of the distribution of R, accumulated until time t, provides expectations for future case numbers DT(t+t) , with quantified credible intervals, via